drugset / Trial / NCT06014606

Learning and Decision-making

NCT06014606

Completed 150 enrolled Maastricht University
RandomizedParallel-groupDouble-blindBasic science

Summary

A fundamental aspect of daily life decision-making involves the evaluation of costs and benefits. Neural systems underlying cost-benefit evaluation have been extensively examined, but the specific role of different neurotransmitters remains unclear. Numerous studies suggest that both dopamine (DA) and norepinephrine (NE) are closely related to reinforcement learning, guided exploration/exploitation, and behavioural energisation, although no studies to date have investigated the distinct role of DA and NE on cost-benefit decision-making and learning in human subjects.

Timeline

Start
2021-03-01
Primary completion
2023-04-30
Completion
2023-08-16

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified 2 mg Oral
Comparator Propranolol Small molecule 40 mg Oral

Indications

No indication recorded.